BioCentury | Jan 28, 2020
Distillery Therapeutics
Inhibiting CD36 to overcome resistance to Tykerb in HER2-positive breast cancer
...Manabu Kurokawa, Dartmouth College, Hanover, N.H.; Kent State University, Kent, Ohio email: mkurokaw@kent.edu
Claire Quang
Tykerb, Tyverb, lapatinib (GW572016)
Dartmouth College
CD36...